HTI-2088 Tablet

· Hengrui Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HTI-2088 Tablet, covering 2017-11-14 to 2017-11-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, Study to Evaluate HTI-2088 Tablet [Phase 1]